Xie Y - Search Results

1

Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation.

Bai R, Yao C, Zhong Z, Ge J, Bai Z, Ye X, Xie T, Xie Y. Bai R, et al. Among authors: xie y, xie t. Eur J Med Chem. 2021 Mar 5;213:113165. doi: 10.1016/j.ejmech.2021.113165. Epub 2021 Jan 9. Eur J Med Chem. 2021. PMID: 33454546 Review.

2

Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains.

Zhou YJ, Liu MS, Osamah AR, Kong XL, Alsam S, Battah S, Xie YY, Hider RC, Zhou T. Zhou YJ, et al. Eur J Med Chem. 2015 Apr 13;94:8-21. doi: 10.1016/j.ejmech.2015.02.050. Epub 2015 Feb 26. Eur J Med Chem. 2015. PMID: 25747496

3

Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives.

Bai R, Sun J, Liang Z, Yoon Y, Salgado E, Feng A, Oum Y, Xie Y, Shim H. Bai R, et al. Among authors: xie y. Eur J Med Chem. 2018 Apr 25;150:195-205. doi: 10.1016/j.ejmech.2018.02.085. Epub 2018 Mar 2. Eur J Med Chem. 2018. PMID: 29529500 Free PMC article.

4

Development of CXCR4 modulators based on the lead compound RB-108.

Bai R, Jie X, Sun J, Liang Z, Yoon Y, Feng A, Oum Y, Yu W, Wu R, Sun B, Salgado E, Xie Y, Shim H. Bai R, et al. Among authors: xie y. Eur J Med Chem. 2019 Jul 1;173:32-43. doi: 10.1016/j.ejmech.2019.03.065. Epub 2019 Apr 5. Eur J Med Chem. 2019. PMID: 30981691 Free PMC article.

5

Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease.

Zhang C, Yang K, Yu S, Su J, Yuan S, Han J, Chen Y, Gu J, Zhou T, Bai R, Xie Y. Zhang C, et al. Among authors: xie y. Eur J Med Chem. 2019 Oct 15;180:367-382. doi: 10.1016/j.ejmech.2019.07.031. Epub 2019 Jul 12. Eur J Med Chem. 2019. PMID: 31325784

6

Dual-target anti-Alzheimer's disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity.

Mi Z, Gan B, Yu S, Guo J, Zhang C, Jiang X, Zhou T, Su J, Bai R, Xie Y. Mi Z, et al. Among authors: xie y. J Enzyme Inhib Med Chem. 2019 Dec;34(1):1489-1497. doi: 10.1080/14756366.2019.1634703. J Enzyme Inhib Med Chem. 2019. PMID: 31416364 Free PMC article.

7

Simultaneous Quantification and Pharmacokinetic Study of Nine Bioactive Components of Orthosiphon stamineus Benth. Extract in Rat Plasma by UHPLC-MS/MS.

Guo Z, Li B, Gu J, Zhu P, Su F, Bai R, Liang X, Xie Y. Guo Z, et al. Among authors: xie y. Molecules. 2019 Aug 22;24(17):3057. doi: 10.3390/molecules24173057. Molecules. 2019. PMID: 31443519 Free PMC article.

8

Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.

Wu R, Yu W, Yao C, Liang Z, Yoon Y, Xie Y, Shim H, Bai R. Wu R, et al. Among authors: xie y. Eur J Med Chem. 2020 Jan 1;185:111823. doi: 10.1016/j.ejmech.2019.111823. Epub 2019 Oct 30. Eur J Med Chem. 2020. PMID: 31698158

9

Discovery of small-molecule candidates against inflammatory bowel disease.

Bai R, Jie X, Yao C, Xie Y. Bai R, et al. Among authors: xie y. Eur J Med Chem. 2020 Jan 1;185:111805. doi: 10.1016/j.ejmech.2019.111805. Epub 2019 Oct 23. Eur J Med Chem. 2020. PMID: 31703817 Review.

10

Fragmentation pathways of deprotonated amide-sulfonamide CXCR4 inhibitors investigated by ESI-IT-MSⁿ , ESI-Q-TOF-MS/MS and DFT calculations.

Guo Z, Jie X, Zhu P, Sun J, Gu J, Su F, Bai R, Xie Y. Guo Z, et al. Among authors: xie y. J Mass Spectrom. 2019 Nov;54(11):869-877. doi: 10.1002/jms.4439. Epub 2019 Nov 20. J Mass Spectrom. 2019. PMID: 31749257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,143 results

Search Page

Filters